BMJ  2005;330:223 (29 January), doi:10.1136/bmj.38308.477650.63 (published 21 December 2004)

Paper

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies

S Darby, professor of medical statistics1, D Hill, statistician1, A Auvinen, professor of epidemiology2, J M Barros-Dios, professor of epidemiology3, H Baysson, statistician4, F Bochicchio, senior researcher5, H Deo, statistician6, R Falk, principal scientist7, F Forastiere, professor of epidemiology8, M Hakama, professor of epidemiology9, I Heid, statistician10, L Kreienbrock, professor of statistics11, M Kreuzer, epidemiologist12, F Lagarde, statistician13, I Mäkeläinen, health physicist14, C Muirhead, statistician15, W Oberaigner, epidemiologist16, G Pershagen, professor of environmental medicine13, A Ruano-Ravina, professor of epidemiology3, E Ruosteenoja, scientist14, A Schaffrath Rosario, statistician10, M Tirmarche, epidemiologist4, L Tomásek, statistician17, E Whitley, visiting lecturer in medical statistics18, H-E Wichmann, professor of epidemiology10, R Doll, emeritus professor of medicine1

1 Clinical Trials Service Unit and Epidemiological Studies Unit, Radcliffe Infirmary, Oxford OX2 6HE, 2 School of Public Health, University of Tampere, Tampere, Finland, 3 Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain, 4 Institut de Radioprotection et de Sûreté Nucléaire, Direction de la Radioprotection de l'Homme, Service de Radiobiologie et d'Epidémiologie, Fontenay-aux-Roses Cedex, France, 5 Unit of Radioactivity and its Health Effects, Department of Technology and Health, Italian National Institute of Health, Rome, Italy, 6 Department of Applied Statistics, University of Reading, Reading RG6 2AL, 7 Swedish Radiation Protection Authority, SE-171 16, Stockholm, Sweden, 8 Department of Epidemiology, Rome E Health Authority, Rome, Italy, 9 Finnish Cancer Registry, Helsinki, Finland, 10 Institute of Epidemiology, GSF Research Centre for Environment and Health, Neuherberg, Germany, 11 Institute of Biometry, Epidemiology and Information Processing, University of Veterinary Medicine, Hannover, Germany, 12 Department of Radiation Protection and Health, Federal Office for Radiation Protection, Neuherberg, Germany, 13 Institute of Environmental Medicine, Karolinska Institute, S-171 77, Stockholm, Sweden, 14 STUK-Radiation and Nuclear Safety Authority, Helsinki, Finland, 15 National Radiological Protection Board, Chilton, Didcot OX11 0RQ, 16 Tumorregister Tirol, Innsbruck, Austria, 17 Epidemiology Unit, National Radiation Protection Institute, Prague, Czech Republic, 18 Department of Social Medicine, University of Bristol, Bristol BS8 2PR

Correspondence to: S Darby sarah.darby{at}ctsu.ox.ac.uk

Objective To determine the risk of lung cancer associated with exposure at home to the radioactive disintegration products of naturally occurring radon gas

Design Collaborative analysis of individual data from 13 case-control studies of residential radon and lung cancer.

Setting Nine European countries.

Subjects 7148 cases of lung cancer and 14 208 controls.

Main outcome measures Relative risks of lung cancer and radon gas concentrations in homes inhabited during the previous 5-34 years measured in becquerels (radon disintegrations per second) per cubic metre (Bq/m3) of household air.

Results The mean measured radon concentration in homes of people in the control group was 97 Bq/m3, with 11% measuring > 200 and 4% measuring > 400 Bq/m3. For cases of lung cancer the mean concentration was 104 Bq/m3. The risk of lung cancer increased by 8.4% (95% confidence interval 3.0% to 15.8%) per 100 Bq/m3 increase in measured radon (P = 0.0007). This corresponds to an increase of 16% (5% to 31%) per 100 Bq/m3 increase in usual radon—that is, after correction for the dilution caused by random uncertainties in measuring radon concentrations. The dose-response relation seemed to be linear with no threshold and remained significant (P = 0.04) in analyses limited to individuals from homes with measured radon < 200 Bq/m3. The proportionate excess risk did not differ significantly with study, age, sex, or smoking. In the absence of other causes of death, the absolute risks of lung cancer by age 75 years at usual radon concentrations of 0, 100, and 400 Bq/m3 would be about 0.4%, 0.5%, and 0.7%, respectively, for lifelong non-smokers, and about 25 times greater (10%, 12%, and 16%) for cigarette smokers.

Conclusions Collectively, though not separately, these studies show appreciable hazards from residential radon, particularly for smokers and recent ex-smokers, and indicate that it is responsible for about 2% of all deaths from cancer in Europe.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Attributable lung cancer risk from radon in homes may be low
Jerome S Puskin and David J Pawel
BMJ 2005 330: 1151. [Extract] [Full Text]

Domestic radon increases the risk of lung cancer
BMJ 2005 330: 0. [Full Text]

Radon blues
Geoff Watts
BMJ 2005 330: 226-227. [Full Text] [PDF]

This article has been cited by other articles:

  • Vanmarcke, H. (2008). Radon: a special case in radiation protection. Radiat Prot Dosimetry 130: 76-80 [Abstract] [Full text]  
  • Chen, J., Jiang, H., Tracy, B. L., Zielinski, J. M. (2008). A preliminary radon map for Canada according to health region. Radiat Prot Dosimetry 130: 92-94 [Abstract] [Full text]  
  • Thomas, J., Tomasek, L., Fojtikova, I., Bernovsky, P. (2008). Cost-effectiveness of countermeasures against radon in the Czech Republic: preliminary report. Radiat Prot Dosimetry 130: 18-21 [Abstract] [Full text]  
  • Laitinen, M., Riihimaki, I., Ekman, J., Sagari, A. R. A., Karlsson, L. B., Sangyuenyongpipat, S., Gorelick, S., Kettunen, H., Penttila, H., Hellborg, R., Sajavaara, T., Helgesson, J., Whitlow, H. J. (2008). MOBILITY DETERMINATION OF LEAD ISOTOPES IN GLASS FOR RETROSPECTIVE RADON MEASUREMENTS. Radiat Prot Dosimetry 0: ncn162v1-5 [Abstract] [Full text]  
  • Tidd, M. J (2008). The big idea: polonium, radon and cigarettes. JRSM 101: 156-157 [Full text]  
  • Wilcox, H. B., Al-Zoughool, M., Garner, M. J., Jiang, H., Klotz, J. B., Krewski, D., Nicholson, W. J., Schoenberg, J. B., Villeneuve, P. J., Zielinski, J. M. (2008). Case-control study of radon and lung cancer in New Jersey. Radiat Prot Dosimetry 128: 169-179 [Abstract] [Full text]  
  • Ruano-Ravina, A., Perez-Becerra, R., Fraga, M., Kelsey, K. T., Barros-Dios, J. M. (2008). Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure. Ann Oncol 19: 109-114 [Abstract] [Full text]  
  • Copes, R. MD MSc, Scott, J. MD (2007). Radon exposure: Can we make a difference?. CMAJ 177: 1229-1231 [Full text]  
  • Kurmi, O.P., Ayres, J.G. (2007). Review Series: Occupational and environmental lung disease: The non-occupational environment and the lung: opportunities for intervention. Chronic Respiratory Disease 4: 227-236 [Abstract]  
  • Alberg, A. J., Ford, J. G., Samet, J. M. (2007). Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 29S-55S [Abstract] [Full text]  
  • Lopez, M. A., Castellani, C. M., Currivan, L., van Dijk, J., Falk, R., Olko, P., Wernli, C. (2007). State-of-the-art dosimetric methods for internal and external exposures: conclusions of a EURADOS action. Radiat Prot Dosimetry 125: 41-46 [Abstract] [Full text]  
  • Wakelee, H. A., Chang, E. T., Gomez, S. L., Keegan, T. H., Feskanich, D., Clarke, C. A., Holmberg, L., Yong, L. C., Kolonel, L. N., Gould, M. K., West, D. W. (2007). Lung Cancer Incidence in Never Smokers. JCO 25: 472-478 [Abstract] [Full text]  
  • Kavasi, N., Nemeth, Cs., Kovacs, T., Tokonami, S., Jobbagy, V., Varhegyi, A., Gorjanacz, Z., Vigh, T., Somlai, J. (2007). Radon and thoron parallel measurements in Hungary. Radiat Prot Dosimetry 123: 250-253 [Abstract] [Full text]  
  • Andersen, C. E., Raaschou-Nielsen, O., Andersen, H. P., Lind, M., Gravesen, P., Thomsen, B. L., Ulbak, K. (2007). Prediction of 222Rn in Danish dwellings using geology and house construction information from central databases. Radiat Prot Dosimetry 123: 83-94 [Abstract] [Full text]  
  • Ghany, H. A. A. (2006). The Association between Indoor Radon and Tobacco Smoke. Indoor and Built Environment 15: 289-293 [Abstract]  
  • Wall, B F, Kendall, G M, Edwards, A A, Bouffler, S, Muirhead, C R, Meara, J R (2006). What are the risks from medical X-rays and other low dose radiation?. Br. J. Radiol. 79: 285-294 [Abstract] [Full text]  
  • Kendall, G M, Muirhead, C R (2005). Moderate dose rate ionizing radiation increases longevity?. Br. J. Radiol. 78: 573-574 [Full text]  
  • Puskin, J. S, Pawel, D. J (2005). Attributable lung cancer risk from radon in homes may be low. BMJ 330: 1151-1151 [Full text]  
  • (2005). Radon in the Home Increases Risk for Lung Cancer. JWatch General 2005: 3-3 [Full text]  
  • Watts, G. (2005). Radon blues. BMJ 330: 226-227 [Full text]  

Rapid Responses:

Read all Rapid Responses

Why risk from radon is larger in smokers?
Parthasarathy K.S.
bmj.com, 24 Dec 2004 [Full text]
Re: Why risk from radon is larger in smokers?
Karl Dr. Martin
bmj.com, 31 Dec 2004 [Full text]
Projecting the Attributable Lung Cancer Risk from Radon in Homes
Jerome S. Puskin, et al.
bmj.com, 3 Feb 2005 [Full text]
Assumptions of constant exposure etc
Grazyna T Adamiak
bmj.com, 26 May 2005 [Full text]
Domestic radon, smoking and lung cancer
Donald J Higson
bmj.com, 8 Nov 2005 [Full text]
Access all current jobs at BMJ Group
Whats new online at Student BMJ
Listen to the latest BMJ Interview